Search results
Results From The WOW.Com Content Network
In 2024, Northwestern led over 6,900 clinical studies with 372,561 study participants,” said Alpesh Patel, MD, Professor and Co-Director of the Northwestern Center for Spine Health. “We are pleased to participate in Aclarion’s CLARITY trial, a groundbreaking randomized controlled trial examining Nociscan’s impact on discogenic low back ...
The North Carolina-based company said it will receive $295 million for its enabling services segment and patient access businesses when the deal closes in the second quarter of 2024, with a ...
Clinical endpoints or clinical outcomes are outcome measures referring to occurrence of disease, symptom, sign or laboratory abnormality constituting a target outcome in clinical research trials. The term may also refer to any disease or sign that strongly motivates withdrawal of an individual or entity from the trial, then often termed a ...
The primary endpoint was the treatment of emergent adverse events. When evaluating the effects of treatment if all people adhered to treatment from a mean baseline body weight of 92.7 kg, people ...
Bayer's (BAYRY) investigational candidate, finerenone, meets primary endpoint in the phase III FIDELIO_DKD study in patients with CKD and T2D.
In clinical trials, the non-opioid medication received high patient satisfaction ratings, with 83% reporting "good" to "excellent" pain relief in real-world applications, Cheng noted.
In April 2006, the company acquired eight early phase clinical pharmacology sites from Radiant Research for $65 million. [ 19 ] [ 20 ] [ 21 ] In June 2006, it acquired Signet Laboratories, a provider of monoclonal antibodies used in the research of cancer, infectious disease, and neurodegenerative disease, for $8.95 million.
Endpoint (chemistry), the conclusion of a chemical reaction, particularly for titration; Outcome measure, a measure used as an endpoint in research; Clinical endpoint, in clinical research, a disease, symptom, or sign that constitutes one of the target outcomes of the trial or its participants